米国臨床腫瘍学会（ASCO）で初めて発表した抗体薬物複合体DS-6000の第1相臨床試験データについて

Daiichi Sankyo Co. Ltd. published this content on June 08, 2022, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 02, 2025 at 08:55 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]